GeneDx Holdings (WGS) Current Leases (2020 - 2021)

GeneDx Holdings (WGS) posted quarterly Current Leases of $3.4 million for Q4 2021, down 2.48% YoY from $3.5 million in Q4 2020, and down 2.48% sequentially from $3.5 million in Q4 2020.

GeneDx Holdings (WGS) Current Leases (2020 - 2021) Analysis & Trends

GeneDx Holdings has disclosed Current Leases across 2 years of filings, most recently posting $3.4 million for Q4 2021.

  • In Q4 2021, Current Leases fell 2.48% year-over-year to $3.4 million; the TTM figure through Dec 2021 stood at $3.4 million (down 2.48% YoY), while the FY2021 annual figure was $3.4 million, down 2.48% from the prior year.
  • Current Leases retreated to $3.4 million in Q4 2021, from $3.5 million in the prior quarter.
  • Over the last five years, Current Leases for WGS reached as high as $3.5 million in Q4 2020 and fell as low as $3.4 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn 53.00 Mn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn -
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn -
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn -
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn -
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn -
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn -
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn -
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn -
10 GeneDx Holdings 2.10 Bn 1.93 Bn 68.21 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 3.42 Mn
Dec 31, 2020 3.51 Mn